International Conference on Pediatric Dermatology and Atopic Dermatitis (ICPDAD - 2026)

The International Conference on Pediatric Dermatology and Atopic Dermatitis (ICPDAD - 2026) will take place on November 28, 2026, in Dammam, Saudi Arabia. Organized under the auspices of the Society for Engineering and Research (SFER), this specialized academic and clinical forum brings together pediatric dermatologists, general dermatologists, pediatricians, allergists, immunologists, and healthcare researchers to discuss the latest clinical advancements and therapeutic paradigms in pediatric skin care. Atopic dermatitis (eczema) and pediatric dermatological disorders represent a significant proportion of childhood outpatient presentations globally. Chronic skin inflammation in infants and children poses unique diagnostic and management challenges, requiring a tailored, multidisciplinary approach that balances therapeutic efficacy with long-term safety. ICPDAD - 2026 serves as an international platform to bridge cutting-edge clinical research with practical bedside management, focusing on early intervention, epidermal barrier repair, targeted biologic therapies, and holistic patient care. The conference curriculum addresses the full spectrum of pediatric skin diseases, offering attending medical professionals comprehensive updates on emerging therapeutic options, including topical calcineurin inhibitors, PDE4 inhibitors, targeted biologics, and systemic JAK inhibitors tailored specifically for pediatric populations. Special emphasis is placed on diagnostic precision across neonatal dermatoses, vascular anomalies, genetic skin conditions, and complex inflammatory skin disorders. Delegates explore the biomechanics of the skin microbiome and epidermal barrier function to better implement personalized trigger avoidance and skin barrier restoration strategies. Furthermore, the program examines the profound psychosocial burden of chronic dermatological conditions— addressing severe itch-scratch cycles, sleep deprivation, and the quality-of-life impact on pediatric patients and their families.Through keynote lectures, scientific paper presentations, interactive expert panel discussions, and collaborative Q&A sessions, ICPDAD - 2026 facilitates high-level knowledge exchange and international research partnerships. By translating novel clinical trial data, advanced drug delivery systems, and updated clinical practice guidelines into actionable bedside strategies, the conference equips healthcare providers with the diagnostic accuracy and clinical confidence required to elevate standards of care in pediatric dermatology.